by Staff Writers
Paris (ESA) Oct 07, 2016
A miniaturised biotech unit developed for the International Space Station is improving medical diagnoses on Earth with affordable automation of small-scale diagnostics. In vitro diagnostics, or IVDs, are tests on samples such as human blood, urine and tissue to look for diseases and infection or to help diagnose a medical condition.
They are used in diabetes, cancer, cardiology, HIV/Aids, autoimmune diseases, drug testing, infectious diseases andmore. As healthcare needs continue to grow, the number of samples to test is rapidly increasing.
With growing demand for clean testing, labs are looking to automation to increase throughput, improve quality and solve handling problems quickly. Many smaller laboratories that still perform IVD manually are also trying totake this step towards automation, but find that existing high-throughput units are too costly.
The answer is orbiting Earth
The unit developed by Verhaertfor the Biolab research facility in Europe's Columbus laboratory on the International Space Station turned out to provide a solution for low-throughput IVD. It is now improving the diagnosis of infectious diseases and cancers here on Earth.
Having to operate on the Space Station, and with the limited time available to astronauts to perform experiments, space laboratories require automated devices with long lifetimes and low maintenance and calibration needs.
Space experiments are typically done on a small scale and require a high level of accuracy. Temperature and risk of contamination must also be carefully managed.
To simplify Biolab experiments in space, Verhaert designed and built a unit for precisely controlling the application of liquid nutrients onto a sample strip.
Reusing this approach and their knowhow on precision dosing and contamination control enabled Verhaert to automate the previously manual work for low-throughput IVD.
"Many general laboratories performing low-throughput IVD have expressed their wish to move towards more automation and integration of their workflows," said Christiaan De Wilde, CEO at Fujirebio Europe.
"These laboratories have been looking in vain for accessible solutions to help them take the important first step towards automation."
The Verhaert space design features a completely new automatic testing mechanism that is cheaper to use, thanks to a higher processing speed, the elimination of maintenance and calibration, and a more efficient use of reagents.
Small laboratories typically perform IVDs manually, which can now be automated, reducing the time needed and the cost. The absence of maintenance and calibration result in lower operating costs.
In August 2015, Fujirebio Europe launched it into the in vitro diagnostics market to handle just 10 IVD strips at a time.
"This diagnostics device is using the same handling mechanism and volumetric dosing architecture we developed for the laboratories on Space Station," says Sam Waes from Verhaert, also the Belgium broker to ESA's Technology Transfer Programme.
"Thanks to this space technology transfer, it has a level of accuracy that is similar to the higher-throughput processors, typically of 48 strips, at a fraction of the cost."
Technology Transfer Programme Office at ESA
Station at NASA
Station and More at Roscosmos
S.P. Korolev RSC Energia
Watch NASA TV via Space.TV
Space Station News at Space-Travel.Com
|The content herein, unless otherwise known to be public domain, are Copyright 1995-2017 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. Privacy Statement|